Overview:

• Technology developer Danaher has acquired molecular diagnostics company Cepheid in a $4 billion deal.
• This is the first significant transaction for Danaher since spinning off its industrial businesses this past July.
• The price tag comes to $53 per outstanding Cepheid share.
• Kirkland & Ellis (Daniel Wolf, Michael Brueck) advised Danaher.
• Fenwick & West (Doug Cogen, Michael Brown) advised Cepheid.

Kurt Stumpo - Journalist - North America and the Caribbean